Hongmei Dong, Ph.D. is an Associate Professor at the Institute of Precision Oncology and Pathology, School of Basic Medical Sciences and Public Health, Jinan University, China. She serves as a Youth Member of the Tumor Biomarkers Professional Committee of the Chinese Anti-Cancer Association, a member of the Guangdong Anti-Cancer Association, and a peer reviewer for journals including Cancer Letters and Oncogene. She has published extensively in journals such as Clinical Cancer Research, PNAS, Cancer Letters, Matrix Biology, Oncogene, JCI Insight, and The Journal of Pathology. Dr. Dong has led multiple projects funded by the National Natural Science Foundation of China and the Guangdong Natural Science Foundation, and her work has been recognized with the Guangdong Provincial Science and Technology Progress Award and the Second Prize of the Guangdong Medical Science and Technology Award. She also holds several authorized invention patents.   

Hongmei Dong, PhD

Associate Professor

Institute of Precision Oncology and Pathology

Main research directions:

• Exosome-based liquid biopsy for cancer diagnosis and biomarker development

• Regulation of the inflammatory tumor microenvironment

• Cancer stem cell biology and translational oncology

• Molecular targets for cancer prevention, early detection, and precision therapy

Representative academic achievements：

Selected papers

1. Dong H#, Lin W#, Du L#, et al. PTPRO suppresses lymph node metastasis of esophageal carcinoma by dephosphorylating MET. Cancer Letters, 2023, 567:216283.

2. Yao Z#, Dong H#, Zhu J#, et al. Age-related decline in hippocampal tyrosine phosphatase PTPRO is a mechanistic factor in chemotherapy-related cognitive impairment. JCI Insight, 2023, 8(14):e166306.

3. Lin Y#, Dong H#, Deng W#, et al. Evaluation of salivary exosomal chimeric GOLM1-NAA35 RNA as a potential biomarker in esophageal carcinoma. Clinical Cancer Research, 2019, 25(10):3035-3045.

Selected funding and honors

• Principal Investigator of the NSFC General Program (2025–2028), NSFC Young Scientists Fund (2019–2022), and two Guangdong Natural Science Foundation projects.

• Recipient of the First Prize of the Shantou Science and Technology Award (2018), the Second Prize of the Guangdong Medical Science and Technology Award (2019), and the Second Prize of the Guangdong Science and Technology Progress Award (2020).

Main academic positions:

Associate Professor, Institute of Precision Oncology and Pathology, School of Medicine, Jinan University

• Youth Committee Member, Tumor Marker Committee, Chinese Anti-Cancer Association

• Member, Guangdong Anti-Cancer Association

• Reviewer for Cancer Letters and Oncogene

E-mail：hmdong0411（126 . com）